Semaglutide—a new treatment for obesity-related heart failure with preserved ejection fraction?

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00653-6/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz-9NY2BFQS1NGJcCv-kPJ_K359OtmSm3pRP45sTS_drPLgLbV6Wu3zu-DBx4O2xf8NbzDeIm_HqtL5nBj-t6cKTxJfguBQ&_hsmi=301366407&utm_content=301366407&utm_source=hs_email